- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.06. | BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 18.06. | BioHarvest Sciences Inc.: BioHarvest Sciences to Present at the 2026 BIO International Convention | 314 | Newsfile | Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 18, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable... ► Artikel lesen | |
| 28.05. | BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 18.05. | BioHarvest expands Tate & Lyle sweetener development deal | 5 | Investing.com | ||
| 18.05. | BioHarvest Sciences Inc.: Tate & Lyle Expands Collaboration with BioHarvest Sciences to Accelerate Next-Generation Sweetener Innovation | 569 | Newsfile | Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 18, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable... ► Artikel lesen | |
| 14.05. | BioHarvest outlines 2026 revenue of $38M-$42M in D2C and $12M-$14M in CDMO activity while targeting 2H 2027 fragrance production | 1 | Seeking Alpha | ||
| 14.05. | BioHarvest Sciences Inc.: BioHarvest Sciences Reports First Quarter 2026 Financial Results and Provides Business Update | 369 | Newsfile | Quarterly revenue up 8% year over year; Annual revenue guidance range remains at $42-$48 million CDMO fragrance and Saffron projects reach successful milestones; First quarter CDMO revenue grew... ► Artikel lesen | |
| BIOHARVEST SCIENCES Aktie jetzt für 0€ handeln | |||||
| 14.05. | BioHarvest Sciences Inc. (BHST) Reports Q1 Loss, Beats Revenue Estimates | 2 | Zacks | ||
| 13.05. | BioHarvest beruft Salzman-Frenkel zur Leiterin der Geschäftsentwicklung | - | Investing.com Deutsch | ||
| 13.05. | BioHarvest appoints Salzman-Frenkel as VP business development | 1 | Investing.com | ||
| 13.05. | BioHarvest Sciences Inc.: BioHarvest Sciences Appoints New Head of Business Development for its CDMO Division | 496 | Newsfile | Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 13, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a leader in Botanical Synthesis... ► Artikel lesen | |
| 13.05. | BioHarvest advances saffron cell bank project to stage 2 | 2 | Investing.com | ||
| 13.05. | BioHarvest erreicht Meilenstein bei der Entwicklung von Safran-Zellkulturen | 4 | Investing.com Deutsch | ||
| 13.05. | BioHarvest Sciences Inc.: BioHarvest Sciences Announces Successful Completion of Stage 1 Development of Saffron Composition for Nutraceutical and Culinary Applications | 239 | Newsfile | - CDMO program advances to Stage 2 of development agreement valued at $1.125 million-Advancement of sustainable solution for the production of saffron, one of the world's most valuable and health-promoting... ► Artikel lesen | |
| 12.05. | BioHarvest secures $1.2M fragrance development contract | 5 | Investing.com | ||
| 12.05. | BioHarvest sichert sich Entwicklungsauftrag über 1,2 Millionen US-Dollar für Duftstoffe | 3 | Investing.com Deutsch | ||
| 12.05. | BioHarvest Sciences Inc.: BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using Its Proprietary Botanical Synthesis Platform | 325 | Newsfile | Source plant is widely regarded as one of the most valuable fragrance raw materials in the worldStage 2 contract follows successful Stage 1 completion in March 2026Vancouver, British Columbia and... ► Artikel lesen | |
| 11.05. | BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 30.04. | BioHarvest Sciences Inc.: BioHarvest Sciences to Report First Quarter 2026 Financial Results on May 14, 2026 | 367 | Newsfile | Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - April 30, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its... ► Artikel lesen | |
| 29.04. | BioHarvest appoints Zaki Rakib as CEO | 2 | Seeking Alpha |
1 2 3 Weiter >>
53 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 50,12 | -1,14 % | Märkte am Morgen: Bayer, Deutsche Bank, SAP, Delivery Hero, Easyjet, ASML | Der DAX hat in der vergangenen Woche abgeliefert. Ein Plus von 4,5 Prozent bedeutet die beste Handelswoche seit April 2025. Vor allem an den letzten Tagen blies der DAX zur Rekordjagd, stellte eine... ► Artikel lesen | |
| PFIZER | 21,185 | -0,05 % | JPMORGAN stuft PFIZER INC auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat das Kursziel für Pfizer von 30 auf 28 US-Dollar gesenkt und die Einstufung auf "Neutral" belassen. Seine Schätzungen für die Quartalszahlen am... ► Artikel lesen | |
| MERCK KGAA | 139,70 | +0,07 % | Zelltherapie verlässt das Labor: Warum jetzt die Produktions-Revolution beginnt | ||
| AURORA CANNABIS | 2,332 | -1,60 % | Aurora Named to TIME Canada's Best Companies 2026 List | ||
| CANOPY GROWTH | 0,859 | +0,40 % | Is Canopy Growth Stock Finally Worth Buying After Losing 99% of Its Value? | ||
| TILRAY BRANDS | 3,875 | +0,13 % | Tilray: Interview With Chairman & CEO Irwin Simon About The Diversified CPG Company | ||
| BRISTOL-MYERS SQUIBB | 50,34 | -0,14 % | Während alle auf KI schauen: Warum Big Pharma Milliarden in Zelltherapien investiert | ||
| DERMAPHARM | 45,500 | -0,11 % | Dividendenbekanntmachungen (29.06.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AGC INC JP3112000009 105 JPY 0,5701 EUR ALTER EGO MEDIA SA GRS541003000 - 0,03 EUR AOZORA BANK LTD JP3711200000 23 JPY 0,1248... ► Artikel lesen | |
| CRONOS GROUP | 2,394 | -0,83 % | Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders | TORONTO, June 22, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") today announced that at its Annual Meeting of Shareholders held on Thursday, June... ► Artikel lesen | |
| DIGICANN VENTURES | 0,002 | 0,00 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| EYEPOINT | 12,500 | -3,85 % | EyePoint, Inc.: EyePoint Announces Third Consecutive Positive DSMC Recommendation for Phase 3 Wet AMD Trials for DURAVYU, Building Confidence Ahead of Mid-2026 Topline Data | - LUGANO topline data on track for mid-2026, with LUCIA readout to follow shortly after - - Continued favorable safety profile observed in masked Phase 3 DURAVYU data, consistent with four previously... ► Artikel lesen | |
| INCYTE | 101,85 | -0,39 % | Incyte Completes Acquisition of Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding its Hematology Portfolio | Acquisition adds VGA039, a novel investigational monoclonal antibody in Phase 3 development for patients with von Willebrand disease (VWD), strengthening Incyte's late-stage pipeline
WILMINGTON,... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 0,835 | -1,07 % | Organigram Global Inc.: Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities | Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram") and Sanity Group GmbH ("Sanity" or "Sanity Group") jointly announced the successful closing of Organigram's previously... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 6,200 | -0,96 % | Canopy, Tilray & Co. zittern: Lässt die DEA Cannabis-Aktien beben? Darauf sollten Anleger ab Montag achten | © Foto: adobe.stock.comJetzt gilt es für den Cannabis-Sektor: Am Montag startet das Anhörungsverfahren der DEA - für viele Unternehmen geht es dabei um alles.Cannabis - Seit April fährt die DEA zweigleisig... ► Artikel lesen | |
| SNDL | 1,135 | 0,00 % | 1CM Inc.: 1CM Provides Update on Arrangement Agreement with SNDL | Toronto, Ontario--(Newsfile Corp. - May 27, 2026) - 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) ("1CM") announces that it does not expect the proposed sale of its Ontario retail locations to... ► Artikel lesen |
Das Unternehmen BIOHARVEST SCIENCES INC kann der Branche Pharma zugeordnet werden. Die relative Kursveränderung beträgt aktuell -6,87 % bei einem Aktienkurs von 2,440 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BIOHARVEST SCIENCES INC finden Sie auf Wallstreet Online.